Ranbaxy gets USFDA nod to sell BP drug
Facebook Twitter google+ RSS Feed

Ranbaxy gets USFDA nod to sell BP drug

By Sources   |   Thursday, 15 September 2005, 07:00 Hrs
Printer Print Email Email
NEW DELHI: India’s biggest pharma company Ranbaxy Laboratories has received U.S. Food and Drug Administration’s approval for selling Benazepril Hydrochloride and Hydroclorothiazide, a high blood pressure drug in the U.S. market

Ranbaxy had got tentative approval for the drug in 2004 for various dosage forms from five mg to 25 mg. The company had yesterday announced the setting up of its subsidiary in Italy to gain further foothold in the European market.

Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT